IgG4-related autoimmune pancreatitis-like mass-forming lesion on a background of immune checkpoint inhibitor immunotherapy

Pathology. 2023 Feb;55(1):133-136. doi: 10.1016/j.pathol.2022.04.010. Epub 2022 Jun 27.

Authors

Benjamin Champion¹, Siaw Ming Chai², Mayank Bhandari³, Dilini Gunawardena²

Affiliations

¹ Department of Anatomical Pathology, PathWest, Fiona Stanley Hospital, Murdoch, WA, Australia. Electronic address: benjamin.champion@health.wa.gov.au.
² Department of Anatomical Pathology, PathWest, Fiona Stanley Hospital, Murdoch, WA, Australia.
³ Department of General Surgery, Fiona Stanley Hospital, Murdoch, WA, Australia.

PMID: 35842321
DOI: 10.1016/j.pathol.2022.04.010

No abstract available

Publication types

Letter

MeSH terms

Autoimmune Diseases* / diagnosis
Autoimmune Diseases* / drug therapy
Autoimmune Pancreatitis* / diagnosis
Autoimmune Pancreatitis* / drug therapy
Humans
Immune Checkpoint Inhibitors
Immunoglobulin G
Pancreatitis* / diagnosis

Substances

Immune Checkpoint Inhibitors
Immunoglobulin G